• Exchange: Munich
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Medicines Co/The

+ Add to Watchlist

MZN:GR

17.969 EUR 0.030 0.17%

As of 03:05:55 ET on 10/22/2014.

Snapshot for Medicines Co/The (MZN)

Open: 18.053 Day's Range: 17.969 - 18.053 Volume: 0
Previous Close: 17.939 52wk Range: 15.755 - 30.112 1-Yr Rtn: -22.37%

Stock Chart for MZN

No chart data available.
  • MZN:GR 17.969
  • 1D
  • 1M
  • 1Y
17.939
Interactive MZN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MZN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 16.4310
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 1.3880
Est. PEG Ratio 1.6431
Market Cap (M EUR) 1,170.29
Shares Outstanding (M) 65.13
30 Day Average Volume 386
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MZN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MZN

The Medicines Company develops products that improve specialized care. The Company markets Angiomax, an anticoagulant approved in the United States and other countries for use in patients undergoing coronary angioplasty procedures.

Clive A MeanwellChairman/CEOGlenn P SblendorioPresident/CFO
Victoria KusiakExec VP/Chief Integrity OfcrBrent FurseExec VP/Chief Customer Officer
More Company Profile & Key Executives for MZN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil